Changing therapeutic paradigms for exudative age-related macular degeneration: Antiangiogenic agents and photodynamic therapy

Expert Opinion on Investigational Drugs

Volumn 8, Issue 12, 1999, Pages 2173-2182

  Ciulla, T A ^a   Danis, R P ^a   Criswell, M ^a   Pratt, L M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Anti angiogenesis; Eye; Photodynamic therapy

Indexed keywords

ALPHA INTERFERON; ANECORTAVE; ANGIOGENESIS INHIBITOR; ANTIBODY; BENZOPORPHYRIN DERIVATIVE; ETIOPURPURIN; GROWTH FACTOR; LUTETIUM; MATRIX METALLOPROTEINASE INHIBITOR; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PREDNISONE; ROSE BENGAL; STEROID; TALAPORFIN; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

CENTRAL SCOTOMA; CLINICAL TRIAL; DRUG CLEARANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SIDE EFFECT; STEROID THERAPY; SUBRETINAL NEOVASCULARIZATION; TOPICAL DRUG ADMINISTRATION; VISUAL IMPAIRMENT;

EID: 0032743792     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.12.2173     Document Type: Review

References (98)